ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   
 Top Breaking News
 Friday, August 01, 2014

M. D. Anderson Cancer Center Postdoc Faked Results Of Novartis AG (NVS) Brain Tumor Study

Biota Pharmaceuticals, Inc. (BOTA) Stock Crashes As Influenza Drug Laninamivir Octanoate Fails Mid-Stage Trial; Stock Down -20.54% At 11:37AM ET

Novartis AG (NVS) Malaria Pill KAE609 Shows Promise As Best Drugs Fail

FDA Green Lights Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company (LLY)'s Jardiance For Type 2 Diabetes

Genmab A/S (GEN.CO), GlaxoSmithKline (GSK)'s Ofatumumab Meets Primary Endpoint In Late-Stage Study

Benefit Of Baxter International, Inc. (BAX)'s Immune Therapy Outweighs Risk: FDA Panel

Novartis AG (NVS) Apologizes For Not Disclosing Side-Effects Of Leukemia Drugs Sooner

AstraZeneca PLC (AZN) Steps Up Push Into Cancer Immunotherapy, Falls Behind Rivals Such As Bristol-Myers Squibb Company (BMY), Merck & Co., Inc. (MRK), And Roche (RHHBY)

More News



 Yesterday's Most Popular News 
Novartis AG (NVS) Apologizes For Not Disclosing Side-Effects Of Leukemia Drugs Sooner

Psychologists Discover A Surprising Thing Happens To Kids Who Read Harry Potter, University of Modena Reveals

AstraZeneca PLC (AZN) Steps Up Push Into Cancer Immunotherapy, Falls Behind Rivals Such As Bristol-Myers Squibb Company (BMY), Merck & Co., Inc. (MRK), And Roche (RHHBY)

BioPharm Executive: Have Drugs Finally Been Priced Too High?

Tree Nuts May Fight Metabolic Disease, Diabetes, St. Michael's Hospital Study

FDA Panel Reviews Safety Of Baxter International, Inc. (BAX)'s Experimental Drug For Immune System Disorders

8 Fascinating Facts About Tears You Need To Know, University of California, Berkeley (CAL) Reveals

FDA Approves Boehringer Ingelheim Pharmaceuticals, Inc.'s Once-A-Day Inhaler Drug Striverdi For Chronic Lung Disease Patients

Drinking In Midlife Doubles Chance Of Memory Problems In Later Life, University of Exeter Study

Light Shed On How Depression Is Related To Dementia, Rush University Medical Center Study


 
-

 Featured Stories
 

  Today's Top Jobs

 Featured Employer
About Genzyme Genzyme is committed to discovering and delivering transformative therapies for patients with rare and special unmet medical needs, providing hope where there was none before. Genzyme has pioneered the development and delivery of transformative therapies for over 30 years. Founded in 1981 in Boston, Massachusetts, Genzyme evolved from a tiny start-up with just a handful of employees to one of the world's leading biotech companies. Acquired by Sanofi in 2011, Genzyme now benefits from the reach and resources of one of the world’s largest pharmaceutical companies, with a shared commitment to improving the lives of patients. Genzyme has long been known for our expertise in the class of rare genetic diseases known as lysosomal storage disorders (LSDs). LSDs remain the heart of our company today, but we have also expanded – through both in-house development and strategic acquisitions and partnerships – to other disease areas such as thyroid cancer and multiple sclerosis. Learn more at www.jobsatgenzyme.com. Follow our jobs on Twitter www.twitter.com/genzymejobs. Follow us on LinkedIn http://www.linkedin.com/company/genzyme. About Sanofi Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets, and animal health. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Show me jobs for this employer

 Careers
 
More Career Tips